| Jodi A Berendzen, MD | |
|
1241 W Stadium Blvd, Suite 102, Jefferson City, MO 65109-6023 | |
| (573) 636-5248 | |
| (573) 636-9390 |
| Full Name | Jodi A Berendzen |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 1241 W Stadium Blvd, Jefferson City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356509871 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2011002800 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital Jefferson City | Jefferson city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson City Medical Group Pc | 1850371089 | 97 |
News Archive
Peregrine Pharmaceuticals, Inc. has announced that results from a Phase I clinical trial of its lead anti-phosphatidylserine (anti-PS) antibody bavituximab in combination with chemotherapy in patients with advanced cancer were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.
The Guardian on Sunday published the winning article and a number of shortlisted articles from its International Development Journalism Competition.
Agfa HealthCare announces today the availability of its newest Direct Radiography (DR) detector, the DX-D 35C, an 11x14 inch sized wireless panel which will be on display in booth #310 at AHRA 2013, the Association for Medical Imaging Management's Annual Meeting, July 28-31, 2013 in Minneapolis, Minnesota.
Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institute (GHRI) scientists.
Thermo Fisher Scientific Inc., the world leader in serving science, today reinforced its ongoing commitment to help its customers accelerate innovation and enhance productivity.
› Verified 8 days ago
| Entity Name | Jefferson City Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336189398 PECOS PAC ID: 1850371089 Enrollment ID: O20040908000924 |
News Archive
Peregrine Pharmaceuticals, Inc. has announced that results from a Phase I clinical trial of its lead anti-phosphatidylserine (anti-PS) antibody bavituximab in combination with chemotherapy in patients with advanced cancer were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.
The Guardian on Sunday published the winning article and a number of shortlisted articles from its International Development Journalism Competition.
Agfa HealthCare announces today the availability of its newest Direct Radiography (DR) detector, the DX-D 35C, an 11x14 inch sized wireless panel which will be on display in booth #310 at AHRA 2013, the Association for Medical Imaging Management's Annual Meeting, July 28-31, 2013 in Minneapolis, Minnesota.
Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institute (GHRI) scientists.
Thermo Fisher Scientific Inc., the world leader in serving science, today reinforced its ongoing commitment to help its customers accelerate innovation and enhance productivity.
› Verified 8 days ago
| Entity Name | Community Health Ctr Of Central Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538213244 PECOS PAC ID: 2062456015 Enrollment ID: O20050610000717 |
News Archive
Peregrine Pharmaceuticals, Inc. has announced that results from a Phase I clinical trial of its lead anti-phosphatidylserine (anti-PS) antibody bavituximab in combination with chemotherapy in patients with advanced cancer were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.
The Guardian on Sunday published the winning article and a number of shortlisted articles from its International Development Journalism Competition.
Agfa HealthCare announces today the availability of its newest Direct Radiography (DR) detector, the DX-D 35C, an 11x14 inch sized wireless panel which will be on display in booth #310 at AHRA 2013, the Association for Medical Imaging Management's Annual Meeting, July 28-31, 2013 in Minneapolis, Minnesota.
Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institute (GHRI) scientists.
Thermo Fisher Scientific Inc., the world leader in serving science, today reinforced its ongoing commitment to help its customers accelerate innovation and enhance productivity.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jodi A Berendzen, MD Po Box 104240, Jefferson City, MO 65110-4240 Ph: (573) 635-5264 | Jodi A Berendzen, MD 1241 W Stadium Blvd, Suite 102, Jefferson City, MO 65109-6023 Ph: (573) 636-5248 |
News Archive
Peregrine Pharmaceuticals, Inc. has announced that results from a Phase I clinical trial of its lead anti-phosphatidylserine (anti-PS) antibody bavituximab in combination with chemotherapy in patients with advanced cancer were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.
The Guardian on Sunday published the winning article and a number of shortlisted articles from its International Development Journalism Competition.
Agfa HealthCare announces today the availability of its newest Direct Radiography (DR) detector, the DX-D 35C, an 11x14 inch sized wireless panel which will be on display in booth #310 at AHRA 2013, the Association for Medical Imaging Management's Annual Meeting, July 28-31, 2013 in Minneapolis, Minnesota.
Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institute (GHRI) scientists.
Thermo Fisher Scientific Inc., the world leader in serving science, today reinforced its ongoing commitment to help its customers accelerate innovation and enhance productivity.
› Verified 8 days ago
Amanda Taube Rodemann, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Suite 102, Jefferson City, MO 65109 Phone: 573-636-5248 Fax: 573-636-9390 | |
Dr. William H. Marshall, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-635-5264 Fax: 573-556-5757 | |
Teri A Deffenbaugh, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St, Ob Gyn Associates, Jefferson City, MO 65101 Phone: 573-632-5510 Fax: 573-632-5810 | |
Serese Yvonne Smith-haxton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1125 Madison St, Jefferson City, MO 65101 Phone: 573-632-5510 Fax: 573-632-5810 | |
Brandi Nichols, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1241 W Stadium Blvd, Jefferson City, MO 65109 Phone: 573-636-5248 Fax: 573-636-9390 | |
Dr. Philo S Su, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2712 Plaza Dr, Jefferson City, MO 65109 Phone: 573-893-5500 |